학술논문

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Document Type
Article
Source
In The Lancet Oncology November 2016 17(11):1569-1578
Subject
Primary Research
Articles
Language
ISSN
1470-2045